Edmonton, May 8, 2025 – Innovotech Inc. (TSX-V: IOT) reports that its subsidiary Innovotech Labs Corporation is receiving advisory services and research and development funding of up to $150,000 CAD from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP) to support the development of new antimicrobial testing services for use with medical devices such as catheters, implants, and wound dressings.
The new testing methods align with upcoming changes in international regulatory standards and medical device manufacturers’ needs in the areas of proliferation, biofilm formation, and translocation of microorganisms.
Innovotech Labs Corporation is also receiving funding of up to $30,000 CAD through the NRC IRAP Youth Employment Program to support the hiring of a young graduate to work on the development of antimicrobial silver compounds with complementary properties to InnovoSIL™-1 silver for expanded applications.
“This NRC IRAP support will help us to deepen our technical bench, problem solve for our customers and deliver solutions that reduce infections and complications for better health outcomes,” said Chief Scientific Officer Patricia Nadworny.
